Patented: see www.takeda.com/en-us/patents Revised: 10/2025 PRINCIPAL DISPLAY PANEL - Kit Carton - 250 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] NDC 0944-4622-01 Single-dose only For Intravenous Administration After Reconstitution Only Lyophilized powder for reconstitution ADYNOVATE and diluent preassembled in BAXJECT III system Rx Only Actual potency Takeda PRINCIPAL DISPLAY PANEL - Barrel Label - 250 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] For Intravenous Administration Only ADYNOVATE and diluent preassembled in BAXJECT III system Directions for use: see package insert Rx Only IU: LOT: EXP: Takeda 6521221 PRINCIPAL DISPLAY PANEL - Blister Label - 250 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] NDC 0944-4622-02 Single-dose only 6521479 For Intravenous Administration Only ADYNOVATE and diluent preassembled in BAXJECT III system Do not open until time of use Do not use if packaging is opened or damaged Discard unused portion
Cautions: If you are pregnant, nursing, have any health condition, or are taking any medication, consult your healthcare professional before using this product
Genetics are often the primary driver of premature graying but environment and lifestyle factors also play a role and can accelerate it. While optimizing glutathione and antioxidant levels can help, Lee said it wont compensate for systemic poor health including smoking, high alcohol intake and processed food-heavy diets
Rustenhoven, J
The MIC compounds support liver health and function, ensuring it can efficiently process fats and eliminate toxins released during weight loss
